文献速递内脏/肾动脉与血管畸形

2000至2012年美国肠系膜缺血治疗与死亡率趋势

Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012.
PubMed 文献 · Ann Vasc Surg · 2017-03-28

基于美国全国住院患者样本与CDC数据库2000至2012年数据,研究分析慢性和急性肠系膜缺血的血管内与开放血运重建趋势。结果显示血管内治疗在两病种均显著增加,开放手术未减少,住院死亡率下降,急性肠系膜缺血的 population 死亡率下降。

要点

  • 慢性肠系膜缺血血管内治疗从0.6增至4.5/百万(P<0.01),开放手术稳定于1–1.1/百万。
  • 急性肠系膜缺血血管内治疗从0.6增至1.8/百万(P<0.01),开放手术稳定于1.8–1.7/百万。
  • 急性肠系膜缺血年 population 死亡率从12.9降至5.3/百万(P<0.01),慢性稳定于0.7–0.6/百万/年。

核心结论

  • 2000至2012年急性肠系膜缺血的 population 死亡率下降,与慢性肠系膜缺血血管内干预大幅增加相关,尽管栓塞切除率稳定。
  • 慢性和急性肠系膜缺血的开放手术率保持稳定,未因血管内治疗增加而下降。

研究设计与样本

  • 基于美国全国住院患者样本(Nationwide Inpatient Sample)和CDC数据库2000至2012年的回顾性趋势分析。
  • 共识别慢性肠系膜缺血血运重建14,810例(血管内10,453例,开放4,358例)和急性肠系膜缺血血运重建11,294例(血管内4,983例,开放6,311例)。
  • 数据经人口增长校正,评估血运重建、死亡率和总死亡数随时间的变化。

主要发现

  • 慢性肠系膜缺血血管内治疗从0.6增至4.5/百万(P<0.01),急性从0.6增至1.8/百万(P<0.01)。
  • 慢性肠系膜缺血开放手术从1增至1.1/百万,急性从1.8降至1.7/百万,均无统计学下降。
  • 急性肠系膜缺血患者中房颤比例(18%)和栓塞切除频率(1/百万/年)保持稳定。
  • 住院死亡率下降:血管内治疗慢性从8%降至3%(P<0.01),急性从28%降至17%(P<0.01);开放治疗慢性从21%降至9%(P<0.01),急性从40%降至25%(P<0.01)。
  • 年 population 死亡率慢性稳定于0.7–0.6/百万/年,急性从12.9降至5.3/百万/年(P<0.01)。

临床怎么用

  • 血管内治疗增加与急性肠系膜缺血 population 死亡率下降相关,支持其在适宜患者中的应用。
  • 开放手术率未下降,提示开放手术仍是肠系膜缺血血运重建的重要组成部分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unknown whether increased endovascular treatment of chronic mesenteric ischemia has led to decreases in open surgery, acute mesenteric ischemia, or overall mortality. The present study evaluates the trends in endovascular and open treatment over time for chronic and acute mesenteric ischemia. METHODS: We identified patients with chronic or acute mesenteric ischemia in the Nationwide Inpatient Sample and Center for Disease Control and Prevention database from 2000 to 2012. Trends in revascularization, mortality, and total deaths were evaluated over time. Data were adjusted to account for population growth. RESULTS: There were 14,810 revascularizations for chronic mesenteric ischemia (10,453 endovascular and 4,358 open) and 11,294 revascularizations for acute mesenteric ischemia (4,983 endovascular and 6,311 open). Endovascular treatment increased for both chronic (0.6-4.5/million, P < 0.01) and acute mesenteric ischemia (0.6-1.8/million, P < 0.01). However, concurrent declines in open surgery did not occur (chronic: 1-1.1/million, acute: 1.8-1.7/million). Among patients with acute mesenteric ischemia, the proportion with atrial fibrillation (18%) and frequency of embolectomy (1/million per year) remained stable. In-hospital mortality rates decreased for both endovascular (chronic: 8-3%, P < 0.01; acute: 28-17%, P < 0.01) and open treatment (chronic: 21-9%, P < 0.01; acute: 40-25%, P < 0.01). Annual population-based mortality remained stable for chronic mesenteric ischemia (0.7-0.6 deaths per million/year), but decreased for acute mesenteric ischemia (12.9-5.3 deaths per million/year, P < 0.01). CONCLUSIONS: Population mortality from acute mesenteric ischemia declined from 2000 to 2012, correlated with dramatic increases in endovascular intervention for chronic mesenteric ischemia, and in spite of a stable rate of embolization. However, open surgery for both chronic and acute ischemia remained stable.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zettervall SL, Lo RC, Soden PA, et al. Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012. Ann Vasc Surg. 2017. PMID: 28359796. doi:10.1016/j.avsg.2017.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。